United Therapeutics to pay $210 million to resolve U.S. kickback probe

BOSTON (Reuters) - United Therapeutics Corp will pay $210 million to resolve U.S. claims that the drugmaker used a charity as a conduit to illegally cover Medicare patients' out-of-pocket drug costs in order to eliminate price sensitivity and to boost sales.